<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04724213</url>
  </required_header>
  <id_info>
    <org_study_id>Pompe_HrQol</org_study_id>
    <nct_id>NCT04724213</nct_id>
  </id_info>
  <brief_title>Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease</brief_title>
  <acronym>Pompe_HrQol</acronym>
  <official_title>Development and Validation of a Standardized Assessment Instrument for Health-related Quality of Life (HrQoL) in Children and Adolescents With Pompe Disease (PD): a Joint Effort of Patients, Caregivers and Metabolic Experts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Children's Hospital, Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Health related quality of life (HrQoL), is &quot;the patient's subjective perception of the impact&#xD;
      of his disease and its treatment on his daily life, physical, psychological and social&#xD;
      functioning and well-being&quot; and thus constitutes a patient reported outcome (PRO) of utmost&#xD;
      importance. Generic HrQoL instruments can by definition not capture disease-specific&#xD;
      parameters nor are they sensitive enough to detect their changes. In this study, a&#xD;
      disease-specific HrQoL questionnaire for children and adolescents will be developed. Patients&#xD;
      and parents will be involved in focus groups and interviews to identify relevant contents.&#xD;
      The instrument will be tested for validity and reliability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reliability/ validity of questionnaire</measure>
    <time_frame>15 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pompe Disease</condition>
  <arm_group>
    <arm_group_label>Testing of reliability / validity of new questionnaire</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Testing of reliability / validity of new questionnaire</intervention_name>
    <description>Participants will answer new questionnaire and other, established, generic and chronic generic HrQol instruments</description>
    <arm_group_label>Testing of reliability / validity of new questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with PD from age 8 years&#xD;
&#xD;
               -  Parent of patient(s) &lt; 18 years with PD&#xD;
&#xD;
               -  Able to give informed consent as documented by signature&#xD;
&#xD;
               -  Sufficient command of the German language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Inability to follow the procedures of the study, e.g. due to language problems or&#xD;
             severely reduced health status&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martina Huemer, Prof dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Childrens Hospital Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martina Huemer, Prof Dr</last_name>
    <phone>+41 44 266</phone>
    <phone_ext>7593</phone_ext>
    <email>martina.huemer@kispi.uzh.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helene Werner, PD Dr.</last_name>
    <phone>+41 44 266</phone>
    <phone_ext>7111</phone_ext>
    <email>helene.werner@kispi.uzh.ch</email>
  </overall_contact_backup>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 20, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease Type II</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

